<DOC>
	<DOCNO>NCT02419417</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , pharmacokinetics , pharmacodynamics BMS-986158 subject select advanced solid tumor .</brief_summary>
	<brief_title>Study BMS-986158 Subjects With Select Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Must triple negative breast cancer , ovarian ( Serous histology expansion phase ) , small cell lung cancer , solid tumor Expected life expectancy least 3 month Men woman 18 year old old At least one measurable lesion baseline CT MRI per response evaluation criterion solid tumor ( RECIST ) v1.1 Eastern Cooperative Oncology Group ( ECOG ) 0 1 Serious uncontrolled medical disorder Concomitant second malignancy Uncontrolled significant cardiovascular disease Inadequate bone marrow function Other protocol define inclusion/exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>